CSS LLC’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

CSS LLC’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42,011	Closed	-$1.72M	–	1074
2024 Q2	$1.72M	Buy	42,011 +8,000	+24%	+$333K	0.09%	160
2024 Q1	$1.44M	Buy	34,011 +13,000	+62%	+$546K	0.08%	195
2023 Q4	$891K	Buy	+21,011	New	+$604K	0.05%	278
2021 Q3	–	Sell	-19,552	Closed	-$501K	–	1328
2021 Q2	$501K	Buy	+19,552	New	+$280K	0.02%	624

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CSS LLC's CERE Position: Q3 2024 in Review

CSS LLC sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 42,011 shares — an estimated $1.72M sold.

CSS LLC first reported a position in CERE in Q2 2021 and held it in 4 quarters. The position peaked at $1.72M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

CSS LLC reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
CSS LLC sold 42,011 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.72M.
CSS LLC first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
CSS LLC's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.72M in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on CSS LLC's 13F filing for Q3 2024, filed 14 Nov 2024.